- Home
- KMPR vs VIR Comparison
KMPR vs VIR Comparison
Compare KMPR & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KMPR | VIR |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KMPR | VIR |
|---|---|---|
| Price | $28.04 | $11.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $47.67 | $19.43 |
| AVG Volume (30 Days) | 813.1K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,789,700,000.00 | $68,556,000.00 |
| Revenue This Year | N/A | $270.22 |
| Revenue Next Year | $4.35 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.26 | N/A |
| 52 Week Low | $22.69 | $4.75 |
| 52 Week High | $53.73 | $11.94 |
Technical Indicators
Market Signals| Indicator | KMPR | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 62.61 |
| Support Level | $27.22 | $8.43 |
| Resistance Level | $30.97 | $11.66 |
| Average True Range (ATR) | 0.93 | 0.64 |
| MACD | 0.17 | 0.16 |
| Stochastic Oscillator | 93.60 | 71.18 |
Price Performance
Historical ComparisonAbout KMPR Kemper Corporation
Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.